Preterm birth continues to be a significant public health problem. Infection (bacterial and or viral) and inflammation, by stimulating proinflammatory cytokines, adhesion molecules, and matrix metalloproteinase 9 (MMP9), play a central role in the rupture of membranes and myometrial contractions. SMAD7 has been implicated in regulating the inflammatory response; however, no studies have been performed with regard to human labor. In this study, we determined the effect of spontaneous human labor and prolabor mediators on SMAD7 expression in myometrium and fetal membranes. Functional studies were employed to investigate the effect of siRNA knockdown of SMAD7 (siSMAD7) in regulating infection and inflammation-induced prolabor mediators. SMAD7 mRNA and protein expression were significantly higher with spontaneous term labor, compared to no labor, in myometrium and fetal membranes. SMAD7 expression was also significantly higher in amnion from women with preterm chorioamnionitis. The proinflammatory cytokines IL1B and TNF, the bacterial product fsl-1, and the viral dsRNA analog poly(I:C) significantly increased SMAD7 in myometrial cells and amnion cells. In myometrial cells, siSMAD7 cells significantly decreased cytokine (IL6) and chemokine (CXCL1, CXCL8, CCL2 are also known as GRO-alpha, interleukin (IL)-8 and monocyte chemotactic protein-1 (MCP-1)) production induced by IL1B, TNF, and fsl-1. There was also a decrease in the expression of adhesion molecules intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1) in siSMAD7 cells, and MMP9 expression. In amnion, siSMAD7 cells treated with IL1B also decreased cytokine and chemokine production, ICAM1 and MMP9 expression. In conclusion, we report a proinflammatory role for SMAD7 in human gestational tissues, with SMAD7 silencing attenuating the inflammatory response.
Introduction
With an estimated 15 million babies born too early in 2010 (a worldwide preterm birth rate of 11.1%) [1] , approximately 1.1 million of these babies will die each year. Those who survive are faced with numerous lifelong effects on neurodevelopmental functioning and increased risk of chronic disease in adulthood [2] . There are disparities in preterm birth rates within countries due to ethnicity [3] , and there is a huge survival and equity gap between the richest and poorest countries. Of 65 countries studied, there has been no change in the proportion of preterm births (32-37 weeks) from 1990 to 2010 [1] . The development of effective therapies for the management of preterm birth lies in the discovery of causal pathways and increased knowledge of the underlying mechanisms of human labor and delivery.
Inflammation is a driving mechanism of both term and preterm parturition [4] . The same terminal pathways are activated; however, term labor is physiological, while preterm labor is pathological. During term labor, there is increased production of proinflammatory cytokines and chemokines in the gestational tissues [5] . Increased expression of cell adhesion molecules such as intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1) [6] regulates the trafficking of leukocytes in the myometrium [7, 8] . Cytokines such as IL1B and TNF, released by leukocytes that infiltrate the uterus, can further activate extracellular matrix (ECM) remodeling enzymes (such as metalloproteinase (MMP)-9) in the myometrium [9] and fetal membranes [10] [11] [12] . This proinflammatory cascade of events leads to preterm birth. As preterm labor is considered the pathological activation of these processes, the regulation of these mediators deserves closer study.
Mothers against decapentaplegic homolog (SMADs) are a group of intracellular proteins that have a critical role in transmitting transforming growth factor beta (TGFB) superfamily ligand signals to the nucleus [13, 14] . Functionally, SMADs fall into three subfamilies: receptor-activated SMADs (R-SMADs: SMAD1, SMAD2, SMAD3, SMAD5, SMAD8), which become phosphorylated by the type I serine-threonine kinase receptors (TβRI); common mediator SMADs (Co-SMADs: SMAD4), which oligomerize with activated R-SMADs; and inhibitory SMADs (I-SMADs: SMAD6 and SMAD7), which are induced by TGFB family members. SMADs have two conserved domains: the N-terminal Mad homology 1 (MH1) which regulates nuclear import and transcription by binding to DNA, and the C-terminal Mad homology 2 (MH2) domains.
Importantly, however, SMADs serve as the substrates for several factors outside the canonical TGFB pathway. For instance, SMAD7 controls myocyte and adipocyte differentiation and tumor cell metastasis independently of TGFB signaling [15] [16] [17] . SMAD7 is involved in diverse biological processes, as illustrated by the variety of stimuli that can regulate its expression, such as interferon-gamma, TNF, shear stress, and UV light [18] [19] [20] [21] . In particular, the function of SMAD7 in immune response and inflammation has been extensively investigated where it has been shown to exert both anti-and proinflammatory actions. In vitro, overexpression of SMAD7 suppresses peritoneal inflammation induced by high glucose and LPS [22] . In vivo, transgenic expression of SMAD7 in the mouse skin is able to reduce inflammatory response and NFKB1 activation [23] ; and overexpression of SMAD7 in the kidney inhibits renal inflammation in a rat remnant kidney disease model [24] and attenuates inflammation in a mouse model of autoimmune crescentic glomerulonephritis [25] . Of interest, inhibition of SMAD7 decreases proinflammatory cytokine production from inflamed mucosal tissue explants from patients with Crohn's disease [26] . Likewise, in vivo studies show that systemic administration of SMAD7 antisense oligonucleotide suppresses inflammation in an experimental autoimmune encephalomyelitis mouse model [27] , and SMAD7 transgenic mice developed a more severe colitis compared to wild-type mice characterized by high levels of proinflammatory cytokines inducing TNF, IL6, and IL17A [28] . Knockdown of SMAD7 with a specific antisense oligonucleotide (mongersen; previously GED0301) in a mouse model of colitis leads to a robust suppression of mucosal inflammation and resolution of colitis [29] , and has been well tolerated and resulted in a reduction of the signs and symptoms of Crohn's disease in an human phase I trial [30] .
To our knowledge, there are no studies on the expression of SMAD7 in human labor. Thus, the aims of this study were to (1) establish the effect of human spontaneous labor on SMAD7 expression in myometrium and fetal membranes; (2) establish the effect of prolabor mediators IL1B, TNF, fsl-1, and poly(I:C) on SMAD7 expression; and (3) determine the effect of SMAD7 siRNA silencing on the production of proinflammatory and prolabor mediators in myometrial and amnion cells.
Methods

Tissue collection
The Research Ethics Committee of Mercy Hospital for Women approved this study. Written, informed consent was obtained from all participating women. All tissues were obtained from women who delivered healthy, singleton infants. All tissues were brought to the research laboratory and processed within 15 min of the Caesarean delivery. For all studies described below, tissues from women with any underlying medical conditions such as diabetes, asthma, polycystic ovarian syndrome, preeclampsia, and macrovascular complications were not included. Additionally, tissues from women with multiple pregnancies, obese women, and fetuses with chromosomal abnormalities were not included. The clinical characteristics of the patients used for the SMAD7 expression studies are described elsewhere [31] .
Fetal membranes were obtained from women at (1) term, no labor undergoing elective Caesarean section (indications for Caesarean section were breech presentation and/or previous Caesarean section) (n = 9 patients; mean gestational age 39.3 ± 0.3 weeks) and (2) term after spontaneous labor, spontaneous membrane rupture, and normal vaginal delivery (n = 9 patients; mean gestational age 40.4 ± 0.2 weeks). Fetal membranes from the nonlaboring group were obtained from the supracervical site (SCS). Identification of the SCS was performed as previously detailed [32] . In the after labor group, fetal membranes were obtained from the site of membrane rupture as previously described [32] . None of the patients received any medications to augment or induce labor, and the average ±SEM length of labor was 8 h 31 min ± 2 h 7 min. Tissue samples were snap-frozen in liquid nitrogen and immediately stored at -80
• C.
Fetal membranes were also obtained from women at preterm birth for two studies: preterm labor and preterm chorioamnionitis. For the preterm labor study, fetal membranes (amnion and choriodecidua) were obtained from the following groups: (i) Caesarean section in the absence of labor with intact membranes (artificial rupture of membranes at delivery; n = 9 patients; mean gestational age 33.3 ± 0.8 weeks); (ii) Caesarean section in the absence of labor with PROM (n = 9 patients; mean gestational age 33.1 ± 1 weeks); and (iii) after spontaneous labor and normal vaginal delivery (n = 9 patients; mean gestational age 33.6 ± 0.7 weeks). For the acute chorioamnionitis study, only amnion was collected as the choriodecidual tissue was degraded and could not be collected. Amnion was collected from (i) Caesarean section in the absence of labor (n = 8 patients; mean gestational age 33.6 ± 0.7 weeks) and (ii) Caesarean section in the absence of labor with histologically confirmed chorioamnionitis (n = 8 patients; mean gestational age 28.5 ± 1.5 weeks). The SCS could not be identified from preterm deliveries and thus, fetal membranes or amnion was obtained 2 cm from the periplacental edge. Indications for preterm delivery (in the absence of labor) were placenta praevia, placental abruption, antepartum hemorrhage (APH), or Rhesus isoimmunization. PPROM was defined as spontaneous rupture of the membranes at less than 37 weeks gestation at least 1 h before the onset of any contractions. All placentas collected from preterm gestations were subject to histopathological examination, and fetal membranes were swabbed for microbiological culture investigations. Acute chorioamnionitis was diagnosed pathologically according to standard criteria which included histological evidence of macrophages and neutrophils permeating the chorionic cell layer and often infiltrating the amniotic cell [33] .
Myometrium was obtained from consenting women at the time of term Caesarean section (≥37 weeks gestation). Myometrial biopsies, obtained from the upper margin of the lower uterine segment incision during the Caesarean section, were collected from two groups of women: (1) pregnant women undergoing elective Caesarean section in the absence of labor (n = 8 patients; mean gestational age 39.4 ± 0.3 weeks) and (2) pregnant women who were delivered during active labor; labor was defined as the presence of regular uterine contractions (every 3-4 min) resulting in cervical effacement and Immunohistochemical expression of SMAD7 (n = 4 patients per group). Sections are representative of one patient sample per group. A negative control is also displayed. Arrows indicate cytoplasmic and nuclear staining. Main image magnification ×250, insert magnification ×100. (B) SMAD7 mRNA expression was analyzed by qRT-PCR and the fold change was calculated relative to the no labor group (n = 8 patients per group). Data are displayed as mean ± SEM. * P < 0.05 vs. term no labor (Student t-test). (C) SMAD7 protein expression was analyzed by western blotting, and Ponceau S stain was used as a loading control (n = 8 patients per group). The fold change was calculated relative to term no labor. Data are displayed as mean ± SEM. * P < 0.05 vs. term no labor (Student t-test). Representative western blot from four patients per group is also shown. Sections are representative of one patient sample per group. A negative control is also displayed. ae: amniotic epithelium; cl: connective tissue layer; ct: cytotrophoblast layer; dec: decidua. Main image magnification ×250, insert magnification ×100. (D, E) Fetal membranes were obtained from women not in labor at preterm Caesarean section with intact membranes (preterm no labor intact; n = 8 patients), from women at preterm Caesarean section not in labor with PROM (preterm no labor PROM; n = 8 patients), and after preterm spontaneous labor onset and delivery (preterm after labor; n = 8 patients). (F, G) Amnion was obtained from women at preterm Caesarean section with or without histological chorioamnionitis (n = 8 patients per group). (B, D, F) SMAD7 mRNA expression was analyzed by qRT-PCR. (C, E, G) SMAD7 protein expression was analyzed by western blotting and normalized to ACTB protein. A representative western blot from four patients per group is also shown. All data are displayed as mean ± SEM. * P < 0.05 vs term no labor (Student t-test); * * P < 0.05 vs. preterm no Labor no chorioamnionitis (Student t-test). dilation (n = 8 patients; mean gestational age 39.8 ± 0.2 weeks). Indications for Caesarean section in the absence of labor were breech presentation and/or previous Caesarean section. Indications for Caesarean section in the laboring samples were for placenta praevia, fetal distress, and delayed labor or failure to progress. There was no difference in maternal age and body mass index, parity, or gestational age of the patients recruited. In the laboring group, none of the patients received any medications to augment or induce labor, and the average length of labor was 10 h ± 6 h 40 min. Tissue samples were snap-frozen in liquid nitrogen and immediately stored at -80
Immunohistochemistry
Immunohistochemistry (IHC) was performed on paraffin sections as described previously [34] using the IHC Select R HRP Detection Set (Merck Millipore; Billerica, MA). Briefly, sections were deparaffinized followed by an antigen retrieval step (boiled in 10 mM Tris, 1 mM EDTA, pH 9.0 for 10 min followed by 20-min incubation) and then endogenous peroxidases were inactivated by adding 3% hydrogen peroxide for 10 min. After blocking (Blocking Reagent: normal goat serum in PBS) for 5 min, sections were incubated with 2.5 μg/ml rabbit polyclonal anti-SMAD7 (cat no. #42-0400; Life Technologies; Mulgrave, Victoria, Australia) in 1% (wt/vol) bovine serum albumin in PBS and incubated in a humidity chamber at 4
• C overnight. Binding sites were labeled with biotin conjugated rabbit anti-goat IgG antibody followed by the streptavidin HRP. Hematoxylin was used for nuclear staining. Negative control slides, where primary antibody was replaced with rabbit IgG, were also performed. Positive controls, which were composite slides with tonsil, breast tumor, and ovarian tumor, were included in each run.
Gene silencing of SMAD7 with siRNA
Fresh amnion (obtained 2 cm from the periplacental edge) and myometrium were obtained from women who delivered healthy, singleton infants at term (37-41 weeks gestation) undergoing elective Caesarean section in the absence of labor. Primary amnion and myometrial cells were isolated and cultured as we have previously described [32, 35] . Cells at approximately 50% confluence were transfected using Lipofectamine 3000 according to the manufacturer's guidelines (Life Technologies). SMAD7 siRNA (siSMAD7) and negative control (siCONT) were obtained from Ambion (Thermo Fisher Scientific; Scoresby, VIC, Australia). Cells were transfected with 50 nM siSMAD7 or 50 nM siCONT in DMEM/F-12 for 48 h followed by treatment with or without 1 ng/mg IL1B, 10 ng/ml TNF, 250 ng/ml fsl-1, or 5 μg/ml poly(I:C) for 24 h. Cells were collected and stored at −80 • C until assayed for mRNA expression by qRT-PCR and protein expression by western blotting as detailed below. Media was collected and stored at −80 • C until assayed for cytokine release as detailed below. Cell viability was assessed by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) proliferation assay as we have previously described [36] . The data are presented as fold change in expression relative to the expression level in the IL1B-, TNF-, fsl-1-, or poly(I:C)-stimulated siCONTtransfected cells, which was set at 1. Each experiment was performed from amnion obtained from six patients and myometrium obtained from seven patients.
RNA extraction and qRT-PCR
RNA extraction and qRT-PCR were performed as previously described [37] . RNA purity and concentration were measured using a NanoDrop ND1000 and determined via the A 260 /A 280 ratio. RNA (0.2 μg) was converted to cDNA using the high-capacity cDNA reverse transcription kit according to the manufacturer's instructions (Applied Biosystems, Waltham, MA). The RT-PCR was performed using the CFX384 Real-Time PCR detection system (Bio-Rad Laboratories, Gladesville, NSW, Australia) using 100 nM of predesigned and validated QuantiTect primers (primer sequences not available) (Qiagen, Chadstone Centre, Victoria, Australia). Average gene Ct values were normalized against two housekeeping genes (YWHAZ and succinate dehydrogenase complex subunit A (SDHA)). Fold differences were determined using the comparative Ct method.
Western blotting
Western blotting was performed as previously described [34] . Membranes were incubated in 1 μg/ml rabbit polyclonal anti-SMAD7 (cat no. #42-0400; Life Technologies). Semiquantitative analysis of the relative density of the bands in western blots was performed using Quantity One 4.2.1 image analysis software (Bio-Rad Laboratories, Hercules, CA). In fetal membranes, the levels of SMAD7 were normalized to the levels of ACTB (Sigma, St. Louis, MO). SMAD7 protein expression in myometrium was normalized to Ponceau S stain, as described previously [37] ; a section of the Ponceau Figure 3 . Effect of prolabor mediators on SMAD7 expression. Human primary (A) myometrial and (B) amnion cells were incubated in the absence or presence of 1 ng/ml IL1B, 10 ng/ml TNF, 250 ng/ml fsl-1, or 5 μg/ml poly(I:C) for 20 h (n = 5 patients). SMAD7 mRNA expression was analyzed by qRT-PCR, and the fold change was calculated relative to basal. Data are displayed as mean ± SEM. * P < 0.05 vs. basal (one-sample t-test). S-stained membrane was chosen which did not show variation with labor status.
Enzyme immunoassays
Assessment of cytokine and chemokine release of IL6 and CXCL8 was performed using the CytoSet sandwich ELISA according to the manufacturer's instructions (Life Technologies). The release of CXCL1, CCL2, sICAM1, and sVCAM1 was performed by sandwich ELISA from R&D Systems (Minneapolis, MN, USA) according to the manufacturer's instructions. The interassay and intraassay coefficients of variation for all assays were less than 10%.
Gelatin zymography
Incubation media was also collected, and assessment of MMP9 was performed by gelatin zymography as previously described [35] . Proteolytic activity was visualized as clear zones of lysis on a blue background of undigested gelatin. Gels were scanned using a ChemiDoc XRS system (Bio-Rad Laboratories, Gladesville, NSW, Australia), inverted, and densitometry performed using Quantity One image analysis software (Bio-Rad Laboratories, Gladesville, NSW, Australia).
Statistical analysis
All statistical analyses were undertaken using GraphPad Prism (GraphPad Software, La Jolla, CA, USA). For two sample comparisons, either a paired or unpaired Student t-test was used to assess statistical significance between normally distributed data; otherwise, the nonparametric Mann-Whitney U test (unpaired) or the Wilcoxon (matched pairs) test was used. For all other comparisons, a repeated measures ANOVA was used with LSD post hoc testing to discriminate among the means. Statistical significance was ascribed to a P value < 0.05. Data are expressed as mean ± SEM.
Results
Expression of SMAD7 in myometrium
Human myometrium was obtained at term Caesarean section in the absence of labor (term, no labor) and at term Caesarean section during spontaneous labor onset (term, in labor). Immunohistochemistry was used to determine the localization of SMAD7 in pregnant myometrium at term ( Figure 1A ). Both cytoplasmic and nuclear SMAD7 proteins were localized to myometrial transverse and longitudinal smooth muscle fibers. Of note, no staining was present in the negative controls. There was stronger SMAD7 stain in laboring myometrium, which is evidenced in Figure 1 , where SMAD7 mRNA ( Figure 1B ) and protein ( Figure 1C ) expression were significantly higher in laboring myometrium compared to nonlaboring myometrium.
Expression of SMAD7 in fetal membranes
The localization of SMAD7 in human term fetal membranes is shown in Figure 2A . Staining was present in amnion epithelial cells, fibroblasts in the connective tissue layer, the chorionic trophoblast layer, and the decidua. SMAD7 expression was both cytoplasmic and nuclear. There was stronger SMAD7 staining in the fetal membranes after term labor. This is evidenced in Figure 2B and C, where SMAD7 mRNA expression ( Figure 2B ) and protein expression ( Figure 2C ) were significantly higher in fetal membranes obtained from women after spontaneous labor onset and delivery at term. On the other hand, SMAD7 mRNA and protein expression were not different between nonlaboring and laboring fetal membranes obtained at preterm, nor from women with PPROM compared to preterm intact membranes ( Figure 2D and E). In amnion, SMAD7 mRNA and protein expression were significantly higher in the preterm group with histological chorioamnionitis compared to the preterm group without histological chorioamnionitis ( Figure 2F and G).
Effect of prolabor mediators on SMAD7 expression
A range of known mediators of spontaneous preterm birth were used to determine which could affect SMAD7 expression in myometrium and fetal membranes. We tested the proinflammatory cytokines IL1B and TNF; the bacterial product and TLR2 ligand fsl-1; and the viral dsRNA analog and TLR3 ligand poly(I:C). As shown in Figure 3 , IL1B, TNF, and fsl-1 significantly increased SMAD7 expression in both myometrium and fetal membranes. Poly(I:C), however, only significantly increased SMAD7 expression in myometrium; there was no effect of poly(I:C) on SMAD7 expression in fetal membranes.
Effect of siSMAD7 on proinflammatory cytokines and chemokines
Loss-of-function studies were next undertaken to investigate if SMAD7 is involved in the genesis of prolabor mediators induced by proinflammatory cytokines (IL1B or TNF), bacterial infection (using the bacterial product fsl-1), or viral infection (using the dsRNA analog poly(I:C)). The efficacy of siSMAD7 is demonstrated in Supplementary Figure S1 . There was a 60% decrease in SMAD7 mRNA expression in human primary myometrial cells and a 65% decrease in SMAD7 mRNA expression in human primary amnion cells. An MTT cell viability assay showed no difference in absorbance between cells transfected with siCONT and siSMAD7.
For subsequent experiments, after siRNA transfection, myometrial cells were treated with IL1B, TNF, fsl-1, or poly(I:C) while amnion cells were treated with IL1B. Figure 4 shows the effect of siSMAD7 on the expression and secretion of IL6 in myometrial cells. Cells transfected with siCONT and treated with IL1B, fsl-1, and poly(I:C) significantly increased IL6 mRNA expression and release. In siSMAD7 cells, there was a significant decrease in IL6 mRNA expression and release when stimulated with IL1B and fsl-1. Although poly(I:C)-induced IL6 mRNA expression and secretion was decreased by ∼50% in siS-MAD7 compared to siCONT-transfected cells, this failed to reach statistical significance. The effect of siSMAD7 on the expression and secretion of chemokines is shown in Figure 5 . Treatment with IL1B, fsl-1, and poly(I:C) all significantly increased CXCL1, CXCL8, and CCL2 mRNA expression and secretion. In cells transfected with siSMAD7, there was a significant decrease in CXCL1, CXCL8, and CCL2 mRNA expression and secretion when stimulated with IL1B and fsl-1. Poly(I:C)-induced CXCL1 and CCL2 mRNA expression and secretion was decreased by ∼50% in siSMAD7 compared to siCONT-transfected cells; however, this failed to reach statistical significance. There was no effect of siSMAD7 on poly(I:C)-induced CXCL8 mRNA expression or secretion. The effect of siSMAD7 on TNF-induced proinflammatory cytokines and chemokines is summarized in Table 1 . Treatment with TNF in siCONT-transfected cells significantly increased IL6, CXCL1, and CCL2 mRNA expression and secretion. Cells transfected with siSMAD7 significantly decreased TNF-induced IL6 and CCL2 mRNA expression and secretion. TNFinduced CXCL1 mRNA expression and secretion was decreased in siSMAD7 compared to siCONT-transfected cells; however, this failed to reach statistical significance.
The effect of siSMAD7 on the expression of IL1B-stimulated cytokines and chemokines in amnion cells is shown in Figure 6 . As expected, treatment with IL1B significantly increased IL6, CXCL1, CXCL8, and CCL2 mRNA expression and secretion. In cells transfected with siSMAD7, there was a significant decrease in IL1B-stimulated CCL2 mRNA expression and secretion. When compared to siCONT-transfected cells, IL1B-induced IL6, CXCL1, and CXCL8 mRNA expression was decreased by ∼50% in siSMAD7-transfected cells; however, this decrease was not significant.
Effect of siSMAD7 on anti-inflammatory cytokines
The effect of siSMAD7 on the expression of the anti-inflammatory cytokines IL4 and IL10 is summarized in Table 2 . In siCONTtransfected myometrial cells, IL1B significantly increased IL10 mRNA expression; however, there was no effect of IL1B on IL4 mRNA expression. The effect of siSMAD7 was a significant augmentation of IL4 and IL10 mRNA expression. On the other hand, there was no effect of siSMAD7 on IL4 or IL10 mRNA expression in the presence of TNF, fsl-1, or poly(I:C). Furthermore, in amnion cells, there was no effect of siSMAD7 on IL4 or IL10 mRNA expression in the presence of IL1B.
Effect of siSMAD7 on adhesion molecules
The effect of siSMAD7 on the expression and secretion of the adhesion molecules ICAM1 and VCAM1 is shown in Figure 7 for myometrium and in Figure 8 for amnion. In myometrial cells, treatment with IL1B significantly increased ICAM1 and VCAM1 mRNA expression and release of sICAM1 and sVCAM1 ( Figure 7A-D) . Cells transfected with siSMAD7 significantly decreased IL1B-induced ICAM1 and VCAM1 mRNA expression and secretion of sICAM1 and sVCAM1. Cells transfected with siSMAD7 and stimulated with TNF significantly decreased secretion of sICAM1; however, the decrease of ICAM1 mRNA was not significant (Figure 7E and F). There was a significant decrease in ICAM1 mRNA expression and secretion of sICAM1 in siSMAD7 cells treated with poly(I:C) ( Figure 7I and J). Cells transfected with siSMAD7 significantly decreased VCAM1 mRNA expression and secretion of sV-CAM1 when stimulated with both TNF and poly(I:C) ( Figure 7G , H, K, L). Likewise, in amnion cells, transfection with siSMAD7 significantly decreased IL1B-induced ICAM1 mRNA expression and release of sICAM1 (Figure 8 ). VCAM1 mRNA expression and sV-CAM1 were not detectable in amnion cells. Figure 9 shows the effect of siSMAD7 on the expression of the ECM degrading and remodeling enzyme MMP9 in myometrial and amnion cells. As expected, in siCONT-transfected cells, IL1B significantly increased MMP9 mRNA expression and secretion of pro-MMP9 in both myometrium ( Figure 9A and B) and amnion ( Figure 9C and D) . The effect of siSMAD7 was a significant decrease in IL1B-induced MMP9 mRNA expression and secretion of pro-MMP9. The active form of secreted MMP9 was not detectable by zymography.
Effect of siSMAD7 on MMP9
Discussion
For the first time, we report that SMAD7 is involved in regulating the mediators that are involved in the terminal processes of human labor and delivery. Specifically, SMAD7 mRNA and SMAD7 protein expression were increased in both myometrium and fetal membranes with term labor and in amnion with preterm chorioamnionitis. Mediators of human labor, IL1B, TNF, and fsl-1, also increased SMAD7 mRNA expression in primary myometrial and amnion cells. The viral dsRNA analog poly(I:C) also significantly increased SMAD7 expression in primary myometrial cells. Functional studies demonstrated that siRNA silencing of SMAD7 decreased the production of proinflammatory cytokines, chemokines, adhesion molecules, and matrix degrading enzyme MMP9 that were stimulated with these labor mediators. In myometrial cells, there was also a corresponding increase in the expression of anti-inflammatory cytokines IL4 and IL10 in siSMAD7-transfected cells in the presence of IL1B.
Human labor is considered an inflammatory response, as infiltrating leukocytes into the fetal membranes and myometrium produce proinflammatory cytokines and chemokines, such as IL6, TNF, and CXCL8 [7, [38] [39] [40] . Subsequently, these proinflammatory cytokines can induce the expression of MMPs and prostaglandins in uterine and gestational tissues [5, 41, 42] . The current study found that SMAD7 mRNA and SMAD7 protein expression are increased with term labor in myometrium and fetal membranes, compared to nonlaboring tissues. Additionally, Table 2 . Effect of siSMAD7 on anti-inflammatroy cytokines in human primary myometrial and amnion cells. SMAD7 mRNA and SMAD7 protein expression were increased in amnion from women with preterm chorioamnionitis. A possible reason for this increase is that term labor and preterm chorioamnionitis are associated with increased leukocyte infiltrate; leukocytes are a rich source of proinflammatory cytokines, which we have shown increase SMAD7 expression ( Figure 3 ). In support, SMAD7 has been found to be increased in macrophages from necrotizing enterocolitis [43] . As we have postulated in previous manuscripts [37, 44] , a possible reason as to why there was no change in SMAD7 expression in fetal membranes with preterm labor or PROM is that there is an overall increase in inflammation with these indicated preterm births [45, 46] , which obscured any further effect of labor or membrane rupture. Regional variation of fetal membranes, i.e., the site over the cervix prone to rupture, compared to distal areas, could also possibly affect SMAD7 expression. In light of human labor being associated with increased inflammation, inflammatory mediators IL1B, TNF, and fsl-1 also increased the expression of SMAD7 in myometrial and amnion cells while poly(I:C) also increased SMAD7 expression in myometrial cells. This is in accordance to other disease states in nongestational tissues; upregulation of SMAD7 has been observed in the inflamed colon of patients with ulcerative colitis [26] as well as in the stomach of patients with Helicobacter pylori infection [47] . Elevated SMAD7 is also observed in a mouse model of colitis [29] .
Furthermore, experiments with cell lines have shown that SMAD7 can be induced by TNF and IL1B [48, 49] . Contrary to these findings, SMAD7 is downregulated in kidney in rat models of nephritis [33, 50] and in the hypertensive heart [51] . Collectively, SMAD7 can have both pro and anti-inflammatory actions, depending on tissue specificity; however, in human gestational tissues, SMAD7 is proinflammatory, where expression is induced by inflammatory states. Term labor is due to physiological activation of the labor processes, while preterm labor is the result of pathological insults, such as bacterial infection and inflammation (for example, from smoking and APH) [4] . Proinflammatory cytokines, such as IL1B and TNF, the bacterial product fsl-1, and the viral dsRNA analog poly(I:C), are all driving mediators of the inflammatory response [52] [53] [54] ; by increasing the production of proinflammatory cytokines and chemokines, the upregulation of MMP9 facilitates cervical remodeling and membrane rupture, and upregulation of prostaglandins drives uterine contractions [9] [10] [11] [12] [55] [56] [57] . Indeed, intraamniotic and/or systemic administration of IL1B, TNF, and poly(I:C) to mice and monkeys induces preterm labor [58] [59] [60] . The actual doses of these mediators in human preterm or term pregnancy are unknown. Thus, the use of these doses may be considered a limitation of our study, reducing the translational impact in developing a treatment. However, these models provide us the means to understand the mechanisms involved in the production of prolabor mediators. In driving the inflammatory response, it is for this reason these mediators are used in term myometrium and fetal membranes as our models of preterm birth. Given that SMAD7 has been shown to regulate inflammation [26, 47] , we sought to determine if the increased SMAD7 expression found with term labor and preterm chorioamnionitis may be involved in the genesis of proinflammatory and prolabor mediators in myometrium and fetal membranes. By using siRNA to silence gene expression of SMAD7, we found that in myometrial cells, siS-MAD7 cells displayed decreased production of the proinflammatory cytokines and chemokines IL6, CXCL2, CXCL8, and CCL2. These cytokines and chemokines are upregulated in the presence of inflammation, and also during term and preterm labor [39] . Concordantly, there was a significant increase in the expression of IL4 and IL10 in myometrial cells in the presence of IL1B. The role of IL4 in human labor is not well described; IL10, however, has been shown to have an important role in modulating resistance to Representative gelatin zymography from one patient is shown. A positive control, using amnion tissue from one patient, shows the presence of both pro and active MMP9. For all data, the fold change was calculated relative to IL1B-stimulated siCONT-transfected cells and data displayed as mean ± SEM.
* P < 0.05 vs.
IL1B-stimulated siCONT-transfected cells (one-way repeated measures ANOVA with post hoc LSD test).
LPS-induced preterm labor in mice [61] . siSMAD7 cells also displayed decreased production of adhesion molecules ICAM1 and VCAM1, which alludes to a role in the trafficking and recruitment of leukocytes; again, this is important in term labor, further contributing to the production of proinflammatory cytokines. Of interest, we found that under stimulation with poly(I:C), there was a decrease in expression of chemokines and adhesion molecules in siSMAD7-transfected cells, but with a range between 20% and 75%, it failed to reach statistical significance. Similarly in amnion cells, siSMAD7 cells showed decreased production of proinflammatory cytokines and chemokines and ICAM1 expression. In the presence of IL1B, siSMAD7 cells displayed decreased MMP9 expression; in myometrial cells, this alludes to SMAD7 affecting cervical ripening, and in amnion cells, a role in cervical remodeling and membrane rupture. A limitation to our study was that the active form of MMP9 was not detectable by zymography. Nevertheless, our findings imply that in human gestational tissues, in our models of inflammation-induced preterm birth, SMAD7 is involved in terminal effector pathways of human labor and delivery; namely, the production of inflammatory cytokines and chemokines, leukocyte recruitment (by affecting adhesion molecules), and in cervical remodeling and the rupture of membranes (by affecting MMP9). It is worth noting that there was wide variation of cellular responsiveness between patient samples. We attempted to measure CD45 mRNA expression to determine whether increased leukocytes were responsible for this. As most samples did not read (or at cycle 39 out of 40), we were unable to verify this and conclude it is a limitation in our study. SMAD7 is a key negative regulator of TGFB signaling [62] . TGFB inhibits prostaglandin production in amnion cells [63] and rescues IL1A and TNFA-induced preterm birth in rabbits [64] . However, we were unable to show any inhibitory effect of TGFB on basal or IL1B-, TNF-, fsl-1, or poly(I:C)-induced markers of inflammation in human fetal membranes, primary amnion cells, myometrium, or primary myometrial cells (data not shown). Our findings are in agreement with studies demonstrating that SMAD7 can exert its actions independently of TGFB signaling [15] [16] [17] . In addition, there is a possibility that other SMAD proteins could regulate the expression of SMAD7. SMAD7 has been shown to interfere with R-SMAD activation and R-SMAD-SMAD4-DNA complex formation [65, 66] . It is thus possible that other SMAD family members have a role in human labor and delivery, or that other molecules compensate for SMAD7 expression and thus its function.
In conclusion, we describe a proinflammatory role for SMAD7 in human gestational tissues. SMAD7 expression was significantly higher in myometrium and fetal membranes with term labor, and in amnion from women with preterm chorioamnionitis. SMAD7 was also upregulated by labor mediators IL1B, TNF, bacterial product fsl-1, and the viral dsRNA analog poly(I:C). Functional studies showed that SMAD7 silencing is associated with an attenuation of the inflammatory response induced by these mediators. Given that inflammation is associated with spontaneous preterm birth [4] , the possibility of a SMAD7 inhibitor as a therapeutic is conceivable; current clinical trials of mongerson are underway for patients with Crohn's disease [30] .
Supplementary data
Supplementary data are available at BIOLRE online. Figure S1 . Efficacy of siSMAD7 knockdown: Human primary (A, B) myometrial and (C, D) amnion cells were transfected with 50 nM siSMAD7 or 50 nM siCONT for 48 h (n = 5 patients). (A, C) SMAD7 mRNA expression was analyzed by qRT-PCR, and the fold change was calculated relative to the siCONTtransfected cells. Data are displayed as mean ± SEM.
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siCONT (one-sample t-test). (B, D) Cell viability was assessed using an MTT assay, and the fold change was calculated relative to the siCONT-transfected cells. Data are displayed as mean ± SEM.
